Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study
The study aimed to investigate the potential of traditional Chinese medicine (TCM) in reducing the risk of macrovascular invasion (MVI) in Chinese patients with hepatocellular carcinoma (HCC). This retrospective analysis involved 2,267 HCC patients treated at our hospital. Propensity score (PS) matc...
Main Authors: | Huiwen Yan, Xinhui Wang, Lihua Yu, Xiaoli Liu, Fengna Yan, Yuqing Xie, Qing Pu, Zhiyun Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1353720/full |
Similar Items
-
Adjuvant Sorafenib for Postoperative Patients with Hepatocellular Carcinoma and Macrovascular Invasion
by: Che-Jui Chang, et al.
Published: (2023-11-01) -
Effects of adjuvant huaier granule therapy on survival rate of patients with hepatocellular carcinoma
by: Ke Shi, et al.
Published: (2023-05-01) -
Adjuvant therapy with Jianpi Huayu decoction improves overall and recurrence-free survival after hepatectomy for hepatocellular carcinoma: a retrospective propensity score-matching study
by: Rui Luo, et al.
Published: (2023-09-01) -
Comparative study on registration application of proprietary Chinese medicine in the Guangdong-Hong Kong-Macau Greater Bay Area of China
by: Zicheng Liu, et al.
Published: (2024-12-01) -
The use of phytotherapy in hepatocellular carcinoma – a systematic review
by: Cristina P. URSU, et al.
Published: (2023-03-01)